my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
ACQUITY PREMIER is specifically designed to improve analyte recovery, reproducibility and sensitivity by minimizing unwanted interactions with the surface that can lead to sample loss - all without time-consuming tasks such as system and column passivation.
Don't deal with long passivation and conditioning times, poor sensitivity, poor peak shapes, complex mobile phases, or high variability from injection to injection and day to day. Make informed decisions and reduce risk as your analyses capture more sample components from the start. Achieve the highest limits of detection, consistent results, and better recovery.
Whether you are working with peptides, glycans, or modified oligos, screening or quantifying small molecules, or detecting or validating biomarkers, ACQUITY Premier helps you get results faster, shorten method development time, and increase overall lab efficiency.
A new Tandem Quadrupole Mass Spectrometer for Quantification with Absolute power
Achieve lower limits of quantitation to meet regulatory requirements ✓ Ensure consistent robustness and reproducibility so you can maintain performance and productivity ✓ Achieve improved environmental sustainability and lower your laboratory operational costs ✓ more
Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors
Waters Corporation announced the appointment of Dan Brennan and Mark Vergnano, to its Board of Directors, effective November 23, 2022. Mr. Brennan currently serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical device company, and ... more
Waters Appoints John M. Ballbach to Board of Directors
Waters Corporation announced the appointment of John M. Ballbach to its Board of Directors, effective October 5, 2021. Mr. Ballbach currently serves on the Board of RPM International, Inc., a leader in specialty coatings, sealants, building materials and related services. Waters also announ ... more
Waters Corporation Appoints Pearl S. Huang to Board of Directors
Waters Corporation announced that Dr. Pearl S. Huang, President and CEO of Cygnal Therapeutics and venture partner at Flagship Pioneering, has been appointed as a Director of Waters Corporation, effective January 1, 2021. “We are pleased to welcome Pearl to the Waters Board of Directors,” ... more
Detection of Per- and Polyfluorinated Alkyl Substances (PFAS) in Environmental Water Samples
Application brief to demonstrate improved sensitivity for detection of per- and polyfluorinated alkyl substances in environmental water samples more
Waters Corporation is a global leader in liquid chromatography (UPLC/HPLC), mass spectrometry (MS), rheology and thermal analysis. The business areas range from research & development, the manufacture and sale of analytical instruments, laboratory software products, column and sample prepar ... more
Since 1958, Waters has offered total solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ... more
Waters Corporation creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide. Pioneering a c ... more
